
Deep Learning In Diagnostics Market Report 2026
Global Outlook – By Component (Software, Hardware, Services), By Deployment Mode (Cloud-Based, On-Premises), By Application (Medical Imaging, Pathology, Genomics, Drug Discovery, Other Applications), By End-User (Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035
Deep Learning In Diagnostics Market Overview
• Deep Learning In Diagnostics market size has reached to $3.49 billion in 2025 • Expected to grow to $16.06 billion in 2030 at a compound annual growth rate (CAGR) of 35.7% • Growth Driver: Rising Healthcare Digitization Driving The Market Growth Due To Increasing Need For Efficient Data Management And Clinical Decision Support • Market Trend: Advancements In AI-Powered Solutions Enhancing Diagnostic Accuracy And Patient Outcomes • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.What Is Covered Under Deep Learning In Diagnostics Market?
Deep learning in diagnostics refers to the use of advanced artificial intelligence techniques, particularly neural networks with multiple layers, to analyze complex medical data such as images, signals, or patient records. It helps in identifying patterns, detecting diseases, predicting outcomes, and supporting clinical decision-making with greater speed and accuracy than traditional methods. The main components of deep learning in diagnostics include software, hardware, and services. Software refers to a set of programs, instructions, or data that tell a computer or device how to perform specific tasks. These are deployed through cloud-based and on-premises methods. These are applied in areas such as medical imaging, pathology, genomics, drug discovery, and others, serving end-users including hospitals, diagnostic laboratories, research institutes, and others.
What Is The Deep Learning In Diagnostics Market Size and Share 2026?
The deep learning in diagnostics market size has grown exponentially in recent years. It will grow from $3.49 billion in 2025 to $4.74 billion in 2026 at a compound annual growth rate (CAGR) of 35.9%. The growth in the historic period can be attributed to increasing digitization of medical imaging, rising diagnostic workload pressures, expansion of radiology and pathology services, growing availability of annotated medical datasets, increasing adoption of clinical decision support.What Is The Deep Learning In Diagnostics Market Growth Forecast?
The deep learning in diagnostics market size is expected to see exponential growth in the next few years. It will grow to $16.06 billion in 2030 at a compound annual growth rate (CAGR) of 35.7%. The growth in the forecast period can be attributed to increasing demand for early disease detection, rising investment in ai-powered diagnostics, expansion of cloud-based diagnostic platforms, growing regulatory approvals for ai tools, increasing focus on workflow automation in healthcare. Major trends in the forecast period include increasing adoption of AI-based medical imaging analysis, growing use of deep learning in disease detection, expansion of automated diagnostic workflows, rising integration of multi-modal clinical data, enhanced focus on diagnostic accuracy.Global Deep Learning In Diagnostics Market Segmentation
1) By Component: Software, Hardware, Services 2) By Deployment Mode: Cloud-Based, On-Premises 3) By Application: Medical Imaging, Pathology, Genomics, Drug Discovery, Other Applications 4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users Subsegments: 1) By Software: Diagnostic Imaging Software, Pathology Analysis Software, Genomic Data Analysis Software 2) By Hardware: Storage Devices, Networking Devices, Diagnostic Imaging Equipment 3) By Services: Deployment And Integration Services, Training And Education Services, Consulting ServicesWhat Is The Driver Of The Deep Learning In Diagnostics Market?
The increasing healthcare digitization is expected to propel the growth of the deep learning in diagnostics market going forward. Healthcare digitization refers to the adoption of digital technologies within healthcare systems to enhance efficiency, accessibility, data management, and overall patient care. The rise in healthcare digitization is driven by its ability to ensure effective management and secure exchange of the rapidly expanding volumes of patient data, supporting better care coordination and informed decision-making. The digitization of healthcare produces vast amounts of data from medical imaging, electronic health records, and connected devices, creating a need for deep learning in diagnostics, as it can efficiently analyze this data and deliver faster, more accurate insights than traditional methods. For instance, in April 2023, FAIR Health Inc., a US-based non-profit organization, showed a 7.3% national increase in telehealth usage, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, the increasing healthcare digitization is driving the growth of the deep learning in diagnostics industry.Key Players In The Global Deep Learning In Diagnostics Market
Major companies operating in the deep learning in diagnostics market are International Business Machines Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Tempus AI Inc., Qure.ai Technologies Pvt. Ltd., Freenome Holdings Inc., PathAI Inc., Aidoc Medical Ltd., Viz.ai Inc., SOPHiA GENETICS SA, Lunit Inc., Paige.AI Inc., Beijing Infervision Technology Co. Ltd., Indica Labs Inc., CureMetrix Inc., Deep Bio Inc., Enlitic Inc., ScreenPoint Medical B.V., VUNO Inc., Mindpeak GmbH, Arterys Inc.Global Deep Learning In Diagnostics Market Trends and Insights
Major companies operating in the deep learning in diagnostics market are focusing on developing advanced solutions, such as AI-driven deep learning solutions, to enhance diagnostic accuracy, speed, and personalized patient care. An AI-driven deep learning solution refers to an advanced system that uses artificial intelligence and layered neural networks to automatically analyze complex medical data, identify patterns, and generate highly accurate diagnostic insights without extensive human intervention. For instance, in May 2025, GE Healthcare Technologies Inc., a US-based medical technology and diagnostics company, launched CleaRecon DL, designed to improve image reconstruction and diagnostic accuracy. It enhances cone-beam CT (CBCT) images by effectively removing streak artifacts, resulting in much clearer and more accurate imaging for interventional procedures. This technology increases clinicians' confidence in interpreting images and improves precision during interventions, with clinical studies showing 98% clearer images and 94% improved confidence. Ultimately, it supports better patient outcomes by streamlining workflow and enabling more effective, image-guided treatments.What Are Latest Mergers And Acquisitions In The Deep Learning In Diagnostics Market?
In April 2024, GE HealthCare, a U.S.-based provider of medical imaging devices, pharmaceutical diagnostics, and digital health solutions, acquired MIM Software for an undisclosed amount. With this acquisition, GE HealthCare aimed to enhance its AI-powered diagnostics and precision-care capabilities by integrating MIM Software’s advanced medical imaging analytics and workflow solutions across oncology, neurology, urology, and cardiology care pathways. MIM Software is a U.S.-based provider of multimodal medical imaging analysis software, including tools for diagnostic imaging, radiation oncology treatment planning, molecular imaging, and digital workflow management for hospitals, imaging centers, and research institutions.Regional Outlook
North America was the largest region in the deep learning in diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Deep Learning In Diagnostics Market?
The deep learning in diagnostics market includes revenues earned by entities by providing services such as customized algorithm development services, real-time diagnostic monitoring services, genomic and biomarker analysis services, patient data integration and interpretation services, and disease risk prediction services. The market value includes the value of related goods sold by the service provider or included within the service offering. The deep learning in diagnostics market also consists of sales of graphics processing units, edge AI devices, AI-enhanced CT scanners, and ultrasound devices. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Deep Learning In Diagnostics Market Report 2026?
The deep learning in diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the deep learning in diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Deep Learning In Diagnostics Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.74 billion |
| Revenue Forecast In 2035 | $16.06 billion |
| Growth Rate | CAGR of 35.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Component, Deployment Mode, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | International Business Machines Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Tempus AI Inc., Qure.ai Technologies Pvt. Ltd., Freenome Holdings Inc., PathAI Inc., Aidoc Medical Ltd., Viz.ai Inc., SOPHiA GENETICS SA, Lunit Inc., Paige.AI Inc., Beijing Infervision Technology Co. Ltd., Indica Labs Inc., CureMetrix Inc., Deep Bio Inc., Enlitic Inc., ScreenPoint Medical B.V., VUNO Inc., Mindpeak GmbH, Arterys Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
